Table 3 Characteristics of study population by vaccine group
All Maternal (N = 16) | Maternal LAIV (N = 10) | Maternal TIV (N = 6) | |
|---|---|---|---|
Gender – n (%) | |||
Female | 16 (100) | 10 (100) | 6 (100) |
Ethnicity – n (%) | |||
Non-Hispanic | 15 (94) | 9 (90) | 6 (100) |
Hispanic | 1 (6) | 1 (10) | 0 |
Race – n (%) | |||
American Indian/Alaskan Native | 0 | 0 | 0 |
Asian | 0 | 0 | 0 |
Hawaiian/Pacific Islander | 0 | 0 | 0 |
Black/African American | 1 (6) | 0 | 1 (17) |
White | 15 (94) | 10 (100) | 5 (83) |
Multi-Racial | 0 | 0 | 0 |
Other/Unknown | 0 | 0 | 0 |
Age (Years) | |||
Mean (STD) | 32.0 (3.6) | 31.4 (3.0) | 32.9 (4.6) |
Median | 31.5 | 30.2 | 33.3 |
Min, Max | (27.6, 39.1) | (28.0, 38.1) | (27.6, 39.1) |
